Blaise Judja-Sato
(MBA, Chief Executive Officer)
social entrepreneur and business executive with global experience
Dr. Georg Ehret
(MD, Chief Medical Officer)
senior cardiovascular risk clinician-scientist in cardiology
Dr. Patrick van den Bogaard
(PhD, Chief Scientific Officer)
innovation and R&D leader in life science and diagnostics
64 Avenue de la Roseraie,
1206 Geneva, Switzerland
www.resiliencetrust.com
AS SURVIVAL RATES FOR INFECTIOUS DISEASES IMPROVE, CARDIOVASCULAR DISEASE (CVD) PRESENTS A MAJOR THREAT WITH TREMENDOUS HUMAN, ECONOMIC AND STRATEGIC IMPLICATIONS.
THE CONVERGENCE OF FIVE ACCELERATING TRENDS CREATES THE UNIQUE OPPORTUNITY TO FUNDAMENTALLY RETHINK CARDIOVASCULAR CARE.
REIMAGINING CARDIOVASCULAR CARE AROUND FOUR PRINCIPLES—ACCESS, QUALITY, AFFORDABILITY AND EFFICIENCY—HAS THE POTENTIAL TO MAKE CARE MORE SUITABLE FOR AFRICA AND CREATE TREMENDOUS BENEFITS.
MAJOR OBSTACLES REMAIN TO SUSTAINABLY TRANSFORMING CARDIOVASCULAR CARE, ON THE SCALE THAT IS REQUIRED, IN AFRICA.
OUR APPROACH REDUCES THE BURDEN ON EXISTING HEALTH FACILITIES AND ENABLES MORE EFFECTIVE USE OF SCARCE RESOURCES. THERE ARE FOUR GUIDING PRINCIPLES.
AT THE HEART OF OUR APPROACH IS A SCALABLE INNOVATION PLATFORM BUILT ON THREE MUTUALLY REINFORCING PILLARS.